Lara Moumné

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease

Lydie Boussicault, Sandro Alves, Antonin Lamazière et al. · Brain · 2016 · 186 citations · Full text

Life Sciences, Biochemistry, Neuroscience +17

Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation

Diane Beysen, Lara Moumné, Reiner A. Veitia et al. · Human Molecular Genetics · 2008 · 80 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

A novel polyalanine expansion in FOXL2: the first evidence for a recessive form of the blepharophimosis syndrome (BPES) associated with ovarian dysfunction

Nallathambi Jeyabalan, Lara Moumné, Diane Beysen et al. · Human Genetics · 2006 · 72 citations

Medicine, Genetics, Molecular Genetics +15

Differential aggregation and functional impairment induced by polyalanine expansions in FOXL2, a transcription factor involved in cranio-facial and ovarian development

Lara Moumné, Aurélie Dipietromaria, Frank Batista et al. · Human Molecular Genetics · 2007 · 69 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Activity-Regulated Cytoskeleton-Associated Protein Accumulates in the Nucleus in Response to Cocaine and Acts as a Brake on Chromatin Remodeling and Long-Term Behavioral Alterations

Marine Salery, Marc Dos Santos, Estefani Saint‐Jour et al. · Biological Psychiatry · 2016 · 65 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17